Cargando…
The correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke treated with clopidogrel for prevention
BACKGROUND: To explore the correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke (IS) treated with clopidogrel for prevention. METHODS: A total of 289 patients with IS treated with clopidogrel regularly were enrolled in this study, and stroke recurrence o...
Autores principales: | Liu, Guohua, Yang, Sufang, Chen, Siqia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440096/ https://www.ncbi.nlm.nih.gov/pubmed/32176040 http://dx.doi.org/10.1097/MD.0000000000019143 |
Ejemplares similares
-
Correlation study of CYP2C19 gene polymorphism and clopidogrel resistance in Han Chinese patients with cerebral infarction in Guizhou region
por: Shi, Guo-Xian, et al.
Publicado: (2021) -
Association of clopidogrel high on-treatment reactivity with clinical outcomes and gene polymorphism in acute ischemic stroke patients: An observational study
por: Fu, Hefei, et al.
Publicado: (2020) -
Efficacy and safety of clopidogrel and/or aspirin for ischemic stroke/transient ischemic attack: An overview of systematic reviews and meta-analysis
por: Yang, Youwen, et al.
Publicado: (2021) -
Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel
por: Ge, Lihong, et al.
Publicado: (2019) -
A possible synergistic effect of MTHFR C677T polymorphism on homocysteine level variations increased risk for ischemic stroke
por: Li, Aifan, et al.
Publicado: (2017)